A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

NCT02007356 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenovirus Infection
EBV
Cytomegalovirus Infections
Cytokine Capture System
Allogenic Disease

Interventions

BIOLOGICAL: IFN-γ positive selected T-cells

Sponsor

University Hospital, Basel, Switzerland